February 28, 2025 — Philadelphia, PA

Feb. 28, 2025, 9 a.m.-4:45 p.m. ET
Thomas Jefferson University
Dorrance H. Hamilton Building
Philadelphia, Pennsylvania
Designed for healthcare professionals specializing in gastroenterology, hepatology, internal medicine, family medicine, general surgery, gynecology, and colorectal surgery, the seventh annual Jefferson Women and Gastroenterology Health Symposium will discuss the medical conditions that are unique to women, occur more frequently in women, or present differently in women. By utilizing emerging scientific and clinical evidence, experts will provide updated approaches to the diagnosis, management and treatment of common gastrointestinal and liver conditions aimed to improve the care of female patient.
Download brochure (PDF)
Learning objectives:
At the conclusion of this activity, healthcare team members will be able to:
- Recognize the burden and the pathophysiology, diagnosis and treatment of alcohol related liver disease.
- Discuss the symptoms, diagnosis and advances in the treatment of non ulcer dyspepsia and SIBO.
- Explain the impact of obesity on IBD and its implications on the treatment of patients with IBD.
- Discuss the diagnosis and management of various gall bladder diseases that can occur in women during pregnancy and in the post partum period.
- Discuss the criteria for the diagnosis , surveillance guidelines and endoscopic treatment of Barrett's esophagus.
- Recognize personal value, the importance of communicating needs, advocating for oneself, and highlighting achievements.
Keynote Speaker:
Anita Afzali, MD, MPH, AGAF
Associate Chief Medical Officer at University of Cincinnati Health
Executive Vice-Chair for clinical operations in the Department of Internal Medicine, University of Cincinnati College of Medicine
Professor in the division of digestive diseases, University of Cincinnati College of Medicine
Co-directors:
Cuckoo Choudhary, MD
The Dorrance H. Hamilton Professor of Medicine, Division Lead for Women, Diversity, inclusion and Equity
Thomas Jefferson University
Philadelphia, PA
Dina L Halegoua-De Marzio, MD
Professor of Medicine
Director, Fatty Liver Center
Transplant Hepatology Fellowship Program Director of Research
Thomas Jefferson University
Philadelphia, PA
Stephanie M Moleski, MD
Associate Professor of Medicine
Thomas Jefferson University Hospital Philadelphia, PA
Credits:
AMA PRA Category 1 Credits™ (5.50 hours), ABIM MOC Part 2 (0.00 hours), ABS CC (5.50 hours), ANCC Contact Hour(s) (5.50 hours), Non-Physician Attendance (5.50 hours), Nursing Pharmacology Credit (0.00 hours), PA Patient Safety and Risk Credit (0.00 hours)
Registration:
Jefferson | In-Person | Virtual | |
---|---|---|---|
Physician | $50 | $100 | |
Nurse/Nurse Practitioner | $25 | $100 | |
Pharmacist | $25 | $100 | |
Dietician | $25 | $100 | |
Other Healthcare Provider | $25 | $100 | |
Resident/Fellow/Medical Student | $0 | $0 |
Non-Jefferson | In-Person | Virtual | |
---|---|---|---|
Physician | $175 | $100 | |
Nurse/Nurse Practitioner | $120 | $100 | |
Pharmacist | $120 | $100 | |
Dietician | $100 | $100 | |
Other Healthcare Provider | $100 | $100 | |
Resident/Fellow/Medical Student | $0 | $0 |
Questions:
Please contact: jeffersoncpd@jefferson.edu
Midwest
If you missed our Midwest workshop, join us in-person or virtually at one of our remaining locations.
University of Chicago
Gleacher Center
Feb. 24, 2024
Course directors:
Northeast
If you missed our Northeast workshop, join us in-person or virtually at one of our remaining locations.
University of Pennsylvania
Jordan Medical Education Center - Law Auditorium
Jan. 20, 2024
Course directors:
Joint Accreditation Statement
CME expiration date: July 14, 2025
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour(s).
Continuing Pharmacy Education
RMEI Medical Education, LLC designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA-4008290-0000-24-006-H01-P)
Type of Activity: Knowledge
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
Method of Participation and Request for Credit
To receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at accreditation@rmei.com.
Users must:
- Read the learning objectives and faculty disclosures
- Participate in the activity
- Complete the activity evaluation
There is no fee to participate.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer Statement
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Financial Relationships
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Faculty
Emily M. Block, APRN, FNP-C, has no relevant financial relationship(s) with ineligible companies to disclose.
Aaron Cohn, MD, has no relevant financial relationship(s) with ineligible companies to disclose.
Parambir Dulai, MD, has relevant financial relationship(s) with AbbVie, Abivax, Adiso, Bristol-Myers Squibb, Geneoscopy, Janssen, Lilly, Pfizer, Roivant, Takeda (Consultant).
Patient participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
Planners and Managers
RMEI Medical Education, LLC planners and managers have no relevant financial relationship(s) with ineligible companies to disclose.